A multifunctional theranostic nanoagent for enhanced HIFU cancer therapy

来源 :第三届全国暨国际超声分子影像及生物效应和治疗学术会议 | 被引量 : 0次 | 上传用户:yangtianmei02
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective To investigate a novel and self-made perfluorohexane-encapsulated hollow mesoporous prussian blue nanoparticles (HMPBs) can enhance the therapy efficiency of tumor ablation by high-intensity focused ultrasound (HIFU).Methods This experiment was divided into three parts.(A) Preparation of the perfluorohexane (PFH)-encapsulated hollow mesoporous prussian blue nanoparticles (HMPBs-PFH).(B) In vitro bovine HIFU ablation experiment.We designed four groups : Group A, only HIFU ; group B, HIFU + PBS; group C, HIFU + HMPBs ; group D, HIFU + HMPBs-PFH,and then the change in the treatment of various groups target gray area, gray value range and coagulation necrosis were measured.(C) Establishment of rabbit liver VX2 breast cancer xenograft model, 21 days after tumor inoculation in the subcutaneous, VX2 breast cancer xenografts in 32 New Zealand white rabbits were randomly divided into more than four groups of eight.The animals were sacrificed and the ablation volume of each group was measured for comparison.Moreover, tumor tissue was also performed to acquire pathological examination.Results Comparison of gray area and the gray value changes in each groups were preformed.① Ablation volume of in-vitro bovine HIFU ablation:Group A and group B had no significant difference (P>0.05),group C is greater than group A and group B (P<0.05), group D is greater than that in group C (P<0.05).② Necrosis range between each groups: Group A and group B had no significant difference (P>0.05),group C is greater than group A and group B (P<0.05), group D is greater than that in group C (P<0.05).③ Tumor ablation volume change and the transition zone of tumor cell apoptosis index were measured.Group A and group B had no significant difference (P>0.05),group C is greater than group A and group B(P<0.05), group D is greater than group C (P<0.05).Conclusion Perfluorohexane-encapsulated hollow mesoporous prussian blue contrast agent nanoparticles can enhance the effects of HIFU therapy,improve prognosis and prolong survival time.The efficacy of these materials is promising in preliminary trials via modifying the acoustic environment of tissues, increasing the ultrasonic cavitation and enhancing the energy deposition.However,the specific mechanism of the enhancement on HIFU treatment should be further explored.
其他文献
Objectives Colorectal cancer (CRC) remains the third most popular cancer in US.CRC biopsy usually shows substantially increased angiogenesis, which is promoted by a number of pro-angiogenic growth fac
会议
Objective To prepare a targeted ultrasound contrast agent (UCA) carrying gene and cell-penetrating peptide (CPP),and to evaluate their targeting affinity for hypoxia human umbilical vein endothelial c
会议
Objective Downregulating the expression of VEGF expression with low-frequency ultrasound and microbubbles, explore the synergy effect of low-frequency ultrasound and immune cells phenotype in anti-tum
会议
Objective The gold nanoparticles were incorporated into PLGA/PFH (Au-PLGA/PFH) particles to observe their enhanced ultrasound imaging and treatment effect in rabbit metastatic lymph nodes.Methods Doub
会议
Objective To develop an safety,injectable and biodegradable material using calcium phosphate cement containing Fe3O4 nanoparticles for minimally invasive magnetic hyperthermia ablation of tumor.Method
会议
Background To study the efficacy of intravenous MSCs transplantation under diagnostic ultrasound (US) irradiated SDF-1-loaded Microbubbles (MBs) on the improvement of MSCs homing and cardiac function
Objective To investigate the utility of fusion imaging of contrast-enhanced ultrasound (CEUS) and contrast-enhanced computed tomography (CT)/magnetic resonance imaging (MRI) before radiofrequency abla
会议
Objective To investigate the transfection efficiency of combining ultrasound targeted microbubble destruction (UTMD) and classic nuclear localization signal (cNLS) peptide for facilitating targeted ge
Objective The separation of tumor diagnosis and treatment is one of major issues in the clinic.Use of activatable theranostics for the combination of diagnosis and treatment of cancer can provide the
会议
Objective The aims of this study were to develop targeted cationic microbubbles conjugated with a CD 105 antibody (CMB 105) for use in targeted vascular endothelial cell gene therapy and ultrasound im
会议